HealthyNCT03272672
Effects of a Valgus Unloader Brace on Medial Femoral Cartilage
A study testing Össür Unloading Knee Brace in people with Healthy, run by University of North Carolina, Chapel Hill at 1 site in United States.
Trial summary
The purpose of this study is to determine the effect of a valgus unloader brace condition on the acute change in medial femoral condyle cartilage morphology using Ultrasound following a standardized walking protocol. Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Össür Unloading Knee Brace
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Sep 2017to 1 Nov 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Uninjured participants. There will be no exclusion based on race, gender or ethnicity.
Who cannot join
- congenital or degenerative joint condition, orthopedic implants, current joint pain (quantified as less than 2 on a 10cm visual analog scale),
- cartilage injury of any joint, lower extremity fracture, or upper extremity fracture within the last year.
- any major ligamentous or cartilage injury of the knee or hip joints, or reported of cartilage injury at the ankle.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
About this study
Official title: Effects of a Valgus Unloader Brace on Medial Femoral Cartilage Changes Following Walking Protocol
The purpose of this study is to determine the effect of a valgus unloader brace condition on the acute change in medial femoral condyle cartilage morphology using Ultrasound following a standardized walking protocol.
Read the detailed description
Participants will report to an initial screening session during which knee alignment will be determined using a long-lever goniometer. For the assessment of baseline knee alignment, the participant will stand with feet facing forward directly underneath corresponding acromion processes and weight evenly distributed. The first axis will be measured from ASIS to midpoint of the patella and the second axis will be measured from the midpoint of the patella to the tibial tuberosity. The valgus angle will be used to determine eligibility for the study. To be eligible for this study, participants must present with a valgus knee alignment angle of ≥180° on the dominant limb defined as the limb the participant would use to kick a ball. Weight and height measurements will also be measured and used to calculate BMI. Once eligible, participants will determine a self-selected walking speed by walking between 2 sets of infrared timing gates (TF100, TracTronix). Starting approximately 5 steps before the first timing gate, participants will be instructed to walk at a speed described as "comfortable walking over a sidewalk". Each participant will complete 3 trials and the average walking speed will be calculated.
Pre-loading Protocol
Participants will report to the laboratory at the same time of day (±2 hours) for both sessions to account for diurnal variations within the cartilage. Upon arrival, participants will sit on a treatment table in the long-sit position with knees fully extended for 45 mins to allow time for cartilage reformation.
Ultrasonographic Assessment of the Femoral Articular Cartilage While seated with their back up against the wall, participants will flex their knee to 140° measured using a manual goniometer while. A measuring tape will be secured to the length of the table so that the position of the posterior calcaneus can be recorded to allow for consistent positioning across trials 15. A LOGIQe US system (General Electric Co., Fairfield, CT) with a 12MHz linear probe will be used to image both the medial and lateral femoral cartilage. The probe will be placed transversely in line between the medial and lateral femoral condyles just superior to the patella and rotated to maximize reflection off the articular cartilage. A transparent grid will be placed over the US screen to improve reproducibility of the US image. The midpoint of the intercondylar groove will be aligned with the center of the grid.
The level of the cartilage-bone interface at the edge of the image on either side will be recorded in order to ensure consistent positioning across US assessments. Three images will be collected of each knee at each time point. Following each loading condition, the participant will be placed in the same position as the pre-loading US assessment using the tape measure. Three images of the femoral cartilage will be recorded from each knee. All post-walking images will be captured within 5 minutes of the loading protocol.
Ultrasonographic Image Analysis All US images will be analyzed with the ImageJ software (National Institutes of Health, Bethesda, MD). Values for all measurement types will be obtained for each of the three images of the dominant limb at each time point (pre and post-walking) and averaged for statistical analysis.
Cartilage Thickness
Cartilage thickness (in millimeters) will be determined at the most inferior point of the intercondylar groove, the midpoint of the medial condyle, and the midpoint of the lateral condyle by drawing a line from the cartilage-bone interface to the synovial space-cartilage interface.
Cartilage Area The femoral cartilage will be divided into medial and lateral sections by identifying the midline at the most inferior point of the intercondylar groove. Each section of the cartilage will be outlined with a polygon function (Figure 1). The area (in square millimeters) of each section will be measured.
Average Cartilage Thickness The area (in square millimeters) of each section as determined in the cartilage area measure will then be divided by the length (in millimeters) of the section measured via a segmented line along the cartilage-bone interface (Figure 2). Average cartilage thickness (in millimeters) measures will be determined for the medial and lateral condyles. Values will be obtained for each of the three images per limb at each time point (pre and post-walking) and averaged for statistical analysis.
Cartilage Loading Protocol Immediately following pre-test ultrasound assessments, participants will be transferred from the table to a wheelchair in order to minimize knee loading not related to the walking condition. During the braced walking condition, a valgus unloader brace (Össür Unloader One®, Össur Americas, Orange County, CA) will be fitted by a certified athletic trainer per manufacturer instructions to the dominant limb while the participant is seated with knee flexed to approximately 80°.
The brace will be maximally adjusted to unload the medial compartment. The participant will take 30 steps to adjust to the brace. Adjustments will then be made as needed if the participant determines the fit is uncomfortable or too loose. The participant will take 30 more steps. Any final adjustments can be made at that point. The participant will then be transferred to and from the treadmill via wheelchair to control the amount of cartilage loading.
Control Protocol In the unbraced condition, the participant will repeat the brace protocol except that the participant will not be fitted with an unloader brace while seated. The participant will take 60 steps to keep the number of steps consistent across trials before being transferred to the treadmill. The participant will remain unbraced for the entire trial.
Loading Protocol Participants will maintain the self-selected walking speed for 5000 steps on a treadmill (4Front, WOODWAY, Waukesha, WI). Self-selected speed will be kept the same across both conditions. Participant will walk for 1 minute to adjust to treadmill. Steps will then be counted for 1 minute, and the time necessary to complete 5000 steps will be calculated (5000 divided by number of steps per minute).
- Conditions
- Healthy
- Being tested
- Össür Unloading Knee Brace
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Össür Unloading Knee BraceOther
Also called Össür Unloader One®
During the braced walking condition, a valgus unloader brace (Össür Unloader One®, Össur Americas, Orange County, CA) will be fitted by a certified athletic trainer per manufacturer instructions to the dominant limb while the participant is seated with knee flexed to approximately 80°.
The brace will be maximally adjusted to unload the medial compartment.
| Study group | Role | What they receive |
|---|---|---|
| Braced | Experimental | Össür Unloading Knee Brace used during walking protocol Receives: Other: Össür Unloading Knee Brace |
| Unbraced | No intervention | Walking protocol without the use of brace |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pre walking - Thickness (mm) of the Medial Femoral Articular Cartilage as measured by ultrasound
Thickness of the articular cartilage on the Medial Femoral condyle will be measured in millimeters
Measured: Prior to the walking protocol
Post walking - Thickness (mm) of the Medial Femoral Articular Cartilage as measured by ultrasound
Thickness of the articular cartilage on the Medial Femoral condyle will be measured in millimeters
Measured: Immediately following the walking protocol (the post-test will be finished within approximately 5 minutes of concluding the walking protocol)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Sep 2017
- Study start1 Sep 2017
- Primary completion1 Nov 2019
- Study completion1 Nov 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by University of North Carolina, Chapel HillThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Joshua Valentine, Principal investigator, University of North Carolina, Chapel HillBrian Pietrosimone, PhD, Study chair, University of North Carolina, Chapel Hill
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03272672
- Sponsor's protocol ID
- 17-0831
- Status last verified
- Mar 2020
- First submitted
- 28 Aug 2017
- Last updated
- 25 Mar 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 25 Mar 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of a Valgus Unloader Brace on Medial Femoral Cartilage Changes Following Walking Protocol
- ClinicalTrials.gov ID
- NCT03272672
- Acronym / sponsor ID
- 17-0831
- Conditions
- Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- University of North Carolina, Chapel HillUniversity, hospital or other
- Study start
- 1 Sep 2017 (actual)
- Primary completion
- 1 Nov 2019 (actual)
- Study completion
- 1 Nov 2019 (actual)
- First posted
- 5 Sep 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the effect of a valgus unloader brace condition on the acute change in medial femoral condyle cartilage morphology using Ultrasound following a standardized walking protocol.
Detailed description
Participants will report to an initial screening session during which knee alignment will be determined using a long-lever goniometer. For the assessment of baseline knee alignment, the participant will stand with feet facing forward directly underneath corresponding acromion processes and weight evenly distributed. The first axis will be measured from ASIS to midpoint of the patella and the second axis will be measured from the midpoint of the patella to the tibial tuberosity. The valgus angle will be used to determine eligibility for the study. To be eligible for this study, participants must present with a valgus knee alignment angle of ≥180° on the dominant limb defined as the limb the participant would use to kick a ball. Weight and height measurements will also be measured and used to calculate BMI. Once eligible, participants will determine a self-selected walking speed by walking between 2 sets of infrared timing gates (TF100, TracTronix). Starting approximately 5 steps before the first timing gate, participants will be instructed to walk at a speed described as "comfortable walking over a sidewalk". Each participant will complete 3 trials and the average walking speed will be calculated.
Pre-loading Protocol
Participants will report to the laboratory at the same time of day (±2 hours) for both sessions to account for diurnal variations within the cartilage. Upon arrival, participants will sit on a treatment table in the long-sit position with knees fully extended for 45 mins to allow time for cartilage reformation.
Ultrasonographic Assessment of the Femoral Articular Cartilage While seated with their back up against the wall, participants will flex their knee to 140° measured using a manual goniometer while. A measuring tape will be secured to the length of the table so that the position of the posterior calcaneus can be recorded to allow for consistent positioning across trials 15. A LOGIQe US system (General Electric Co., Fairfield, CT) with a 12MHz linear probe will be used to image both the medial and lateral femoral cartilage. The probe will be placed transversely in line between the medial and lateral femoral condyles just superior to the patella and rotated to maximize reflection off the articular cartilage. A transparent grid will be placed over the US screen to improve reproducibility of the US image. The midpoint of the intercondylar groove will be aligned with the center of the grid.
The level of the cartilage-bone interface at the edge of the image on either side will be recorded in order to ensure consistent positioning across US assessments. Three images will be collected of each knee at each time point. Following each loading condition, the participant will be placed in the same position as the pre-loading US assessment using the tape measure. Three images of the femoral cartilage will be recorded from each knee. All post-walking images will be captured within 5 minutes of the loading protocol.
Ultrasonographic Image Analysis All US images will be analyzed with the ImageJ software (National Institutes of Health, Bethesda, MD). Values for all measurement types will be obtained for each of the three images of the dominant limb at each time point (pre and post-walking) and averaged for statistical analysis.
Cartilage Thickness
Cartilage thickness (in millimeters) will be determined at the most inferior point of the intercondylar groove, the midpoint of the medial condyle, and the midpoint of the lateral condyle by drawing a line from the cartilage-bone interface to the synovial space-cartilage interface.
Cartilage Area The femoral cartilage will be divided into medial and lateral sections by identifying the midline at the most inferior point of the intercondylar groove. Each section of the cartilage will be outlined with a polygon function (Figure 1). The area (in square millimeters) of each section will be measured.
Average Cartilage Thickness The area (in square millimeters) of each section as determined in the cartilage area measure will then be divided by the length (in millimeters) of the section measured via a segmented line along the cartilage-bone interface (Figure 2). Average cartilage thickness (in millimeters) measures will be determined for the medial and lateral condyles. Values will be obtained for each of the three images per limb at each time point (pre and post-walking) and averaged for statistical analysis.
Cartilage Loading Protocol Immediately following pre-test ultrasound assessments, participants will be transferred from the table to a wheelchair in order to minimize knee loading not related to the walking condition. During the braced walking condition, a valgus unloader brace (Össür Unloader One®, Össur Americas, Orange County, CA) will be fitted by a certified athletic trainer per manufacturer instructions to the dominant limb while the participant is seated with knee flexed to approximately 80°.
The brace will be maximally adjusted to unload the medial compartment. The participant will take 30 steps to adjust to the brace. Adjustments will then be made as needed if the participant determines the fit is uncomfortable or too loose. The participant will take 30 more steps. Any final adjustments can be made at that point. The participant will then be transferred to and from the treadmill via wheelchair to control the amount of cartilage loading.
Control Protocol In the unbraced condition, the participant will repeat the brace protocol except that the participant will not be fitted with an unloader brace while seated. The participant will take 60 steps to keep the number of steps consistent across trials before being transferred to the treadmill. The participant will remain unbraced for the entire trial.
Loading Protocol Participants will maintain the self-selected walking speed for 5000 steps on a treadmill (4Front, WOODWAY, Waukesha, WI). Self-selected speed will be kept the same across both conditions. Participant will walk for 1 minute to adjust to treadmill. Steps will then be counted for 1 minute, and the time necessary to complete 5000 steps will be calculated (5000 divided by number of steps per minute).
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Braced | Experimental | Other: Össür Unloading Knee BraceÖssür Unloading Knee Brace used during walking protocol |
| Unbraced | No intervention | –Walking protocol without the use of brace |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Uninjured participants. There will be no exclusion based on race, gender or ethnicity.
Key exclusion criteria (3 listed)
- congenital or degenerative joint condition, orthopedic implants, current joint pain (quantified as less than 2 on a 10cm visual analog scale),
- cartilage injury of any joint, lower extremity fracture, or upper extremity fracture within the last year.
- any major ligamentous or cartilage injury of the knee or hip joints, or reported of cartilage injury at the ankle.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Össür Unloading Knee BraceAlso: Össür Unloader One®During the braced walking condition, a valgus unloader brace (Össür Unloader One®, Össur Americas, Orange County, CA) will be fitted by a certified athletic trainer per manufacturer instructions to the dominant limb while the participant is seated with knee flexed to approximately 80°. The brace will be maximally adjusted to unload the medial compartment. | Other | Braced |
Primary outcome
Pre walking - Thickness (mm) of the Medial Femoral Articular Cartilage as measured by ultrasound
Time frame: Prior to the walking protocol
Thickness of the articular cartilage on the Medial Femoral condyle will be measured in millimeters
Post walking - Thickness (mm) of the Medial Femoral Articular Cartilage as measured by ultrasound
Time frame: Immediately following the walking protocol (the post-test will be finished within approximately 5 minutes of concluding the walking protocol)
Thickness of the articular cartilage on the Medial Femoral condyle will be measured in millimeters
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Mar 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Joshua Valentine principal investigator
University of North Carolina, Chapel Hill
Brian Pietrosimone, PhD study chair
University of North Carolina, Chapel Hill
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Össür Unloading Knee Brace in people with Healthy, run by University of North Carolina, Chapel Hill at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pre walking - Thickness (mm) of the Medial Femoral Articular Cartilage as measured by ultrasound (time frame: Prior to the walking protocol). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2020.